Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuldeep K Roy

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Molecules (Basel, Switzerland)|October 17, 2018
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse AgonistsPankaj Pandey, Kuldeep K Roy, Haining Liu, et al.
Chemical Biology & Drug Design|December 24, 2021
Structure-based discovery of (S)-2-amino-6-(4-fluorobenzyl)-5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione as low nanomolar, orally bioavailable autotaxin inhibitorAshis Roy, Tonmoy Sarkar, Sebak Datta, et al.
Chemical Biology & Drug Design|November 2, 2022
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further explorationMrinalkanti Kundu, Aditi Dutta, Kuldeep K Roy, et al.
Msphere|January 10, 2020
Puupehenone, a Marine-Sponge-Derived Sesquiterpene Quinone, Potentiates the Antifungal Drug Caspofungin by Disrupting Hsp90 Activity and the Cell Wall Integrity PathwaySiddharth K Tripathi, Qin Feng, Li Liu, et al.
Bioorganic & Medicinal Chemistry|January 24, 2015
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosisSupriya Singh, Kuldeep K Roy, Shaheb R Khan, et al.
Journal of Medicinal Chemistry|January 25, 2014
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonistsAkshata Nayak, Girish Chandra, Inah Hwang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Molecules (Basel, Switzerland)|October 17, 2018
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse AgonistsPankaj Pandey, Kuldeep K Roy, Haining Liu, et al.
Chemical Biology & Drug Design|December 24, 2021
Structure-based discovery of (S)-2-amino-6-(4-fluorobenzyl)-5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione as low nanomolar, orally bioavailable autotaxin inhibitorAshis Roy, Tonmoy Sarkar, Sebak Datta, et al.
Chemical Biology & Drug Design|November 2, 2022
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further explorationMrinalkanti Kundu, Aditi Dutta, Kuldeep K Roy, et al.
Msphere|January 10, 2020
Puupehenone, a Marine-Sponge-Derived Sesquiterpene Quinone, Potentiates the Antifungal Drug Caspofungin by Disrupting Hsp90 Activity and the Cell Wall Integrity PathwaySiddharth K Tripathi, Qin Feng, Li Liu, et al.
Bioorganic & Medicinal Chemistry|January 24, 2015
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosisSupriya Singh, Kuldeep K Roy, Shaheb R Khan, et al.
Journal of Medicinal Chemistry|January 25, 2014
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonistsAkshata Nayak, Girish Chandra, Inah Hwang, et al.
Pageof 5